NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,697 | +3.5% | 2,850 | 0.0% | 0.00% | – |
Q2 2023 | $1,639 | -18.2% | 2,850 | 0.0% | 0.00% | – |
Q1 2023 | $2,003 | -68.9% | 2,850 | 0.0% | 0.00% | – |
Q4 2022 | $6,441 | -28.4% | 2,850 | 0.0% | 0.00% | – |
Q3 2022 | $9,000 | -18.2% | 2,850 | 0.0% | 0.00% | – |
Q2 2022 | $11,000 | -26.7% | 2,850 | 0.0% | 0.00% | – |
Q1 2022 | $15,000 | -61.5% | 2,850 | 0.0% | 0.00% | – |
Q4 2021 | $39,000 | -23.5% | 2,850 | 0.0% | 0.00% | – |
Q3 2021 | $51,000 | +4.1% | 2,850 | 0.0% | 0.00% | – |
Q2 2021 | $49,000 | -14.0% | 2,850 | 0.0% | 0.00% | – |
Q1 2021 | $57,000 | +18.8% | 2,850 | 0.0% | 0.00% | – |
Q4 2020 | $48,000 | +2.1% | 2,850 | 0.0% | 0.00% | – |
Q3 2020 | $47,000 | -28.8% | 2,850 | 0.0% | 0.00% | – |
Q2 2020 | $66,000 | +29.4% | 2,850 | 0.0% | 0.00% | – |
Q1 2020 | $51,000 | -17.7% | 2,850 | 0.0% | 0.00% | – |
Q4 2019 | $62,000 | +17.0% | 2,850 | -1.2% | 0.00% | – |
Q3 2019 | $53,000 | -47.5% | 2,885 | +1.2% | 0.00% | -100.0% |
Q2 2019 | $101,000 | – | 2,850 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |